India Inc is set to double capex to US$ 850 billion by 2030, led by power, aviation, and green hydrogen, with top firms funding growth through strong balance sheets and policy tailwinds.

For the first time since 2011, public sector banks (PSBs) have outpaced private banks in loan growth, gaining market share and signalling a shift in lending dynamics with potential implications for ...

India reaffirms its Foreign Direct Investment (FDI) strength with a 143% rise since 2014, attracting US$ 81.04 billion in FY25 alone, its highest in three years, underscoring investor confidence ...

India aims to achieve US$ 35.09 billion in defence exports by 2029, reflecting its transformation into a global supplier, alongside major strides in infrastructure, digital payments, and poverty ...

HSBC Mutual Fund (MF) remains optimistic about Indian equities, citing favourable valuations and a revival in growth momentum.

India’s digital public infrastructure, led by Unified Payments Interface (UPI) and Direct Benefit Transfer (DBT), has transformed financial inclusion and efficiency, drawing global acclaim as the ...

India’s Maternal Mortality Ratio fell from 130 to 80 per lakh live births (2014-2016 to 2021-2023) due to the Pradhan Mantri Surakshit Matritva Abhiyan and allied maternal health programmes.

Shein and Reliance Retail plan to scale India’s supplier base from 150 to 1,000 within a year, launching India-made Shein apparel for domestic and global markets to diversify.

Prime Minister Mr. Narendra Modi marked 11 years of leadership, highlighting India’s rapid economic rise, inclusive governance, and transformative welfare initiatives for marginalised communities.

India’s agricultural output has risen 40% in the past decade, with 5.4% growth in Q4 FY25, reflecting self-sufficiency, export strength, and proactive government-farmer-scientist collaboration.

Uttar Pradesh aims to attract US$ 1.40 billion in private investment for a 1,472-acre Bulk Drug Pharma Park in Lalitpur, targeting self-reliance and job creation while also expanding medical ...

India’s pharmaceutical market grew 7.2% in May 2025, driven by price hikes and new launches, with chronic therapies and smaller segments like urology and antineoplastics seeing strong double-digit ...